Neuroblastoma Clinical Trials in Dallas, Texas

9 studies are recruiting for neuroblastoma in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

   This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuxima…

   Stage

   Phase 3

   Ages

   Up to 30

   Site

   Medical City Dallas Hospital, Dallas, Texas

   Locations

   179 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT06172296 on ClinicalTrials.gov

2. Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

   A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Newly Diagnos…

   Stage

   Phase 2

   Ages

   Up to 22

   Site

   Children's Medical Center, Dallas, Texas

   Locations

   28 in total

   Run by

   Giselle Sholler

   See if you can join NCT02559778 on ClinicalTrials.gov

3. Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

   The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other regulatory authorities around the world for use alone …

   Stage

   Phase 1

   Ages

   Up to 26

   Site

   Children's Medical Center, Dallas, Texas

   Locations

   14 in total

   Run by

   Milton S. Hershey Medical Center

   See if you can join NCT06465199 on ClinicalTrials.gov

4. Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

   The purpose of this study is to evaluate the investigational drug, tipifarnib (a pill taken by mouth), in combination with the Food and Drug Administration (FDA) approved drug, naxitimab, administered intravenously (IV; a liquid that continuously goes into your body through a tube that has been pla…

   Stage

   Phase 2

   Ages

   1 to 21

   Site

   Children's Medical Center, Dallas, Texas

   Locations

   12 in total

   Run by

   Giselle Sholler

   See if you can join NCT06540963 on ClinicalTrials.gov

5. Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

   The purpose of this study is to evaluate the investigational drug, silmitasertib (a pill taken by mouth), in combination with FDA approved drugs for solid tumors. An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other regulatory authori…

   Stage

   Phase 1

   Ages

   Up to 30

   Site

   Children's Medical Center, Dallas, Texas

   Locations

   23 in total

   Run by

   Milton S. Hershey Medical Center

   See if you can join NCT06541262 on ClinicalTrials.gov

6. Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

   This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Lor…

   Stage

   Phase 3

   Ages

   1 to 30

   Site

   UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas

   Locations

   164 in total

   Run by

   Children's Oncology Group

   See if you can join NCT03126916 on ClinicalTrials.gov

7. NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

   This is a phase II study looking at patient response to treatment with the combination dinutuximab, temozolomide, irinotecan, and GM-CSF.

   Stage

   Phase 2

   Ages

   1 to 31

   Site

   University of Texas Southwestern, Dallas, Texas

   Locations

   13 in total

   Run by

   New Approaches to Neuroblastoma Therapy Consortium

   See if you can join NCT06450041 on ClinicalTrials.gov

8. Neuroblastoma Biology Study

   Medical scientists want to find better ways to treat neuroblastoma and to find ways to prevent the tumor from growing back. To do this, they need more information about the characteristics of neuroblastoma cells. Therefore, they want to study samples of neuroblastoma tissues and neuroblastoma and n…

   Stage

   Not phased

   Ages

   0 to 99

   Site

   University of Texas Southwestern, Dallas, Texas

   Locations

   17 in total

   Run by

   New Approaches to Neuroblastoma Therapy Consortium

   See if you can join NCT01587300 on ClinicalTrials.gov

9. Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

   The goal of this study is to test if the addition of a novel income-poverty targeted supportive care intervention (Pediatric Resource Intervention to Support Equity [Pediatric RISE]) to usual supportive care for low-income children with high-risk neuroblastoma can improve parent- and child-centered…

   Stage

   Not phased

   Ages

   Up to 17

   Site

   University of Texas Southwestern Medical Center, Dallas, Texas

   Locations

   6 in total

   Run by

   Dana-Farber Cancer Institute

   See if you can join NCT06831552 on ClinicalTrials.gov